Edition:
United States

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

6.92USD
15 Dec 2017
Change (% chg)

$-0.34 (-4.68%)
Prev Close
$7.26
Open
$7.25
Day's High
$7.32
Day's Low
$6.90
Volume
5,572
Avg. Vol
12,489
52-wk High
$13.50
52-wk Low
$2.30

Latest Key Developments (Source: Significant Developments)

Cellect Biotechnology reports Q3 ‍loss $0.02/shr​
Wednesday, 22 Nov 2017 07:00am EST 

Nov 22 (Reuters) - Cellect Biotechnology Ltd :Cellect Biotechnology Ltd provides corporate update and reports third quarter 2017 financial results.Cellect Biotechnology Ltd - qtrly ‍loss per share $0.02​.  Full Article

Cellect Biotechnology announces $4.3 million raise in a registered direct offering
Thursday, 7 Sep 2017 09:43am EDT 

Sept 7 (Reuters) - Cellect Biotechnology Ltd :Cellect Biotechnology announces $4.3 million raise in a registered direct offering.Cellect Biotechnology Ltd - ‍entered into securities purchase agreements with certain accredited investors to receive gross proceeds of $4.3 million​.Cellect Biotechnology Ltd -in connection with offering, co will issue 531,136 adss at a purchase price of $8.10 per ads.  Full Article

FDA grants orphan drug status to Cellect's Apograft for acute GVHD and chronic GVHD
Tuesday, 5 Sep 2017 07:02am EDT 

Sept 5 (Reuters) - Cellect Biotechnology Ltd :FDA grants orphan drug status to Cellect's Apograft for acute GVHD and chronic GVHD.‍FDA granted orphan drug designation for Apograft for prevention of acute and chronic GVHD in transplant patients​.  Full Article

Cellect Biotechnology - Locust Walk engaged to seek strategic licensing deals and global pharma partnerships for commercialization of Cellect's Apograft
Monday, 7 Aug 2017 07:00am EDT 

Aug 7 (Reuters) - Cellect Biotechnology Ltd :Cellect Biotechnology - Locust Walk engaged to seek strategic licensing deals and global pharma partnerships for commercialization of Cellect's Apograft.  Full Article

Cellect Biotechnology files for mixed shelf of upto $75 mln
Tuesday, 1 Aug 2017 04:51pm EDT 

Aug 1 (Reuters) - Cellect Biotechnology Ltd ::Cellect Biotechnology ltd files for mixed shelf of upto $75 million - sec filing.  Full Article

UnicoCell Biomed says 2016 dividend record date is Aug. 25
Monday, 24 Jul 2017 05:32am EDT 

July 24 (Reuters) - UnicoCell Biomed Co Ltd <6539.TWO> ::* Says it will pay cash dividend and stock dividend worth totaling T$3 per share, for 2016 to shareholders with record date on Aug. 25.  Full Article

Cellect gets green light from FDA for ApoGraft IND submission
Wednesday, 3 May 2017 07:01am EDT 

May 3 (Reuters) - Cellect Biotechnology Ltd :Cellect gets green light from FDA for ApoGraft IND submission in the U.S..Cellect biotechnology - U.S. FDA provided Cellect with pre-investigational new drug meeting minutes supporting an IND submission in U.S. for ApoGraft.Cellect Biotechnology Ltd- submission review included manufacturing (cmc) aspects, pre-clinical data and scope and design of future clinical program..  Full Article

Cellect Biotechnology receives formal notice of intention to grant for a patent from European patent office
Monday, 3 Apr 2017 06:02am EDT 

Cellect Biotechnology Ltd :Cellect Biotechnology Ltd- received a formal notice of intention to grant for a patent covering a key method of treatment from European patent office.  Full Article

Cellect Biotechnology reports qtrly loss per share $0.007
Thursday, 23 Mar 2017 07:05am EDT 

Cellect Biotechnology Ltd : Cellect biotechnology provides corporate update and reports fourth quarter and full year 2016 financial results .Qtrly loss per share $0.007.  Full Article

Cellect announces positive clinical trial results
Tuesday, 21 Feb 2017 07:01am EST 

Cellect Biotechnology Ltd : Cellect announces positive clinical trial results .Cellect Biotechnology Ltd - announced today positive final results from its clinical trial of apograft in healthy donors.  Full Article

No consensus analysis data available.